Hepatitis C virus infection and hepatocellular carcinoma.
about
Naturally Occurring Hepatitis C Virus Subgenomic Deletion Mutants Replicate Efficiently in Huh-7 Cells and Are trans-Packaged In Vitro To Generate Infectious Defective ParticlesAssociation between hepatitis C and hepatocellular carcinomaIL28B genetic variations are associated with high sustained virological response (SVR) of interferon-α plus ribavirin therapy in Taiwanese chronic HCV infection.Matrix conditions and KLF2-dependent induction of heme oxygenase-1 modulate inhibition of HCV replication by fluvastatin.Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Epithelial Malignant Tumors from Digestive SystemOncogenic potential of hepatitis C virus proteinsAlcohol and hepatitis C virus--interactions in immune dysfunctions and liver damage.Prevalence of hepatitis C infection in New York City, 2004Prevalence and risk factors of asymptomatic hepatitis C virus infection in bangladesh.Human bile as a rich source of biomarkers for hepatopancreatobiliary cancers.NMR spectroscopy for discovery and quantitation of biomarkers of disease in human bile.Identifying the targets for treatment of liver fibrosis and hepatocellular carcinoma from both Western medicine and Chinese medicine.Safety of telaprevir for chronic hepatitis C virus infection: a meta-analysis of randomized controlled trials.Evidence for association between hepatitis C virus and Parkinson's disease.The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response.Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with or without Ribavirin for Treatment of Hepatitis C Virus Genotype 1: A Systematic Review and Meta-analysis.Visualization of bile homeostasis using (1)H-NMR spectroscopy as a route for assessing liver cancerDecreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.Transporter expression in non-cancerous and cancerous liver tissue from donors with hepatocellular carcinoma and chronic hepatitis C infection quantified by LC-MS/MS proteomics.
P2860
Q27489540-746F85B7-E263-4178-86A6-E01398D60D36Q27491295-8E0AB529-0D40-4BA2-8670-1A337A7236F7Q35042843-DA672456-9D31-4769-BD02-25445FB2B5ABQ35163716-474D1E71-915E-4968-8AA7-D35EB62165D1Q35200716-6139D584-9661-460A-B21D-147ECB63C54DQ35261292-4BE73C4B-8A73-47AF-9C36-05E2AD6977D0Q35660303-B6BF1DDB-6A19-43E9-86DA-786FDF9BEE01Q37470465-9EFA6E14-2B1A-471D-BB03-7992F8F2DCF6Q37613115-0E854D04-033F-4EBD-9136-ADB94EF8CE15Q37734427-3BDBD386-5953-4C95-BFC6-6E219F9543AFQ37923938-4E45136C-9417-4D68-B961-D61DEA77432CQ37997974-4256CF75-6F23-4272-80AA-7187EA9A2998Q38034258-4C97DDE9-26F7-4A1C-97B2-9F71FD403DC3Q38638550-4FBC354F-F8C1-453A-9980-5886084DF07FQ39913123-7C048FB8-C55A-4050-8AB4-473224DDAC9BQ40058097-A9AB6B30-E81B-4566-84A6-78EE90064128Q41935417-C3E2F764-D602-4062-AB38-6E7C399ECE3CQ44135004-DEBFF1BC-27E2-4067-B21A-41D4783799FFQ47402203-94458F1B-448C-4197-8502-64E84A3E534A
P2860
Hepatitis C virus infection and hepatocellular carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatitis C virus infection and hepatocellular carcinoma.
@en
Hepatitis C virus infection and hepatocellular carcinoma.
@nl
type
label
Hepatitis C virus infection and hepatocellular carcinoma.
@en
Hepatitis C virus infection and hepatocellular carcinoma.
@nl
prefLabel
Hepatitis C virus infection and hepatocellular carcinoma.
@en
Hepatitis C virus infection and hepatocellular carcinoma.
@nl
P1476
Hepatitis C virus infection and hepatocellular carcinoma.
@en
P2093
Wojciech Blonski
P304
P356
10.1016/J.CLD.2008.03.007
P577
2008-08-01T00:00:00Z